Abstract
Background
Angiotensin II (AII) and transforming growth factor-β (TGF-β) are closely involved in the pathogenesis of diabetic nephropathy (DN). AII is known to induce TGF-β production in resident renal cells, including glomerular mesangial cells and tubular epithelial cells. TGF-β receptor types I and II (TGF-βRI, II) are up-regulated in the diabetic kidney. The aim of this study was to clarify the role of AII in the regulation of the TGF-β system in the early stage of DN using AII type1a receptor-deficient(AT1a−/−) mice.
Methods
We investigated the expression of TGF-β1, TGF-βRI, II, and Smad signaling in AT1a−/− mice with streptozotocin (STZ)-induced DN. Mice were killed 10 and 20 days after the induction of hyperglycemia. The expression of TGF-β receptors was analyzed by immunohistochemical staining and reverse transcriptase–polymerase chain reaction (RT–PCR). TGF-β-specific Smad signaling was analyzed by electrophoretic mobility shift assay and Western blotting.
Results
The expression of both TGF-βRI and RII was up-regulated in the glomerular tufts and vasculature in diabetic AT1a+/+ mice kidney by immunohistochemistry. RT–PCR revealed that mRNAs for TGF-βRI and RII were also up-regulated. Smad2 and 4 protein levels were reduced in the renal cortex after the induction of diabetes, with an increase of Smad 3/4 complex in the nucleus. The expression of TGF-β receptors increased in both diabetic AT1a−/− and AT1a+/+ mice. Smad signaling in AT1a−/− mice was also enhanced.
Conclusions
Our results suggest that the complete blockade of the AT1a-mediated pathway has a minimal effect on the enhanced TGF-β/Smad signaling in the early stage of DN, at least in the AT1a−/− model.
Similar content being viewed by others
References
G Wolf FN Ziyadeh (1999) ArticleTitleMolecular mechanisms of diabetic renal hypertrophy Kidney Int 56 393–405 Occurrence Handle10432377 Occurrence Handle10.1046/j.1523-1755.1999.00590.x Occurrence Handle1:CAS:528:DyaK1MXltlOhurs%3D
H Makino N Kashihara H Sugiyama K Kanao T Sekikawa K Okamoto et al. (1996) ArticleTitlePhenotypic modulation of the mesangium reflected by contractile proteins in diabetes Diabetes 45 488–95 Occurrence Handle8603771 Occurrence Handle10.2337/diabetes.45.4.488 Occurrence Handle1:CAS:528:DyaK28Xjs1Gjtbc%3D
AE Raptis G Viberti (2001) ArticleTitlePathogenesis of diabetic nephropathy Exp Clin Endocrinol Diabetes 109 IssueIDSuppl 2 S424–37 Occurrence Handle11460589 Occurrence Handle10.1055/s-2001-18600 Occurrence Handle1:CAS:528:DC%2BD3MXlslKnsr8%3D
G Wolf FN Ziyadeh (1997) ArticleTitleThe role of angiotensin II in diabetic nephropathy: emphasis on nonhemodynamic mechanisms Am J Kidney Dis 29 153–63 Occurrence Handle9002545 Occurrence Handle1:STN:280:ByiC2Mngs1w%3D
DJ Leehey AK Singh N Alavi R Singh (2000) ArticleTitleRole of angiotensin II in diabetic nephropathy Kidney Int Suppl 77 S93–8 Occurrence Handle10997697 Occurrence Handle10.1046/j.1523-1755.2000.07715.x Occurrence Handle1:CAS:528:DC%2BD3cXms1Oiu7o%3D
C Hill A Logan C Smith H Gronbaek A Flyvbjerg (2001) ArticleTitleAngiotensin-converting enzyme inhibitor suppresses glomerular transforming growth factor beta receptor expression in experimental diabetes in rats Diabetologia 44 495–500 Occurrence Handle11357481 Occurrence Handle10.1007/s001250051648 Occurrence Handle1:CAS:528:DC%2BD3MXit1GitbY%3D
H Peters WA Border NA Noble (1998) ArticleTitleTargeting TGF-beta overexpression in renal disease: maximizing the antifibrotic action of angiotensin II blockade Kidney Int 54 1570–80 Occurrence Handle9844133 Occurrence Handle10.1046/j.1523-1755.1998.00164.x Occurrence Handle1:CAS:528:DyaK1cXnsVeqtLo%3D
EJ Lewis LG Hunsicker RP Bain RD Rohde (1993) ArticleTitleThe effect of angiotensin-converting-enzyme inhibition on diabetic nephropathy. Collaborative Study Group N Engl J Med 329 1456–62 Occurrence Handle8413456 Occurrence Handle10.1056/NEJM199311113292004 Occurrence Handle1:STN:280:ByuD3MbmtFM%3D
BM Brenner ME Cooper D de Zeeuw WF Keane WE Mitch HH Parving et al. (2001) ArticleTitleEffects of losartan on renal and cardiovascular outcomes in patients with type 2 diabetes and nephropathy N Engl J Med 345 861–9 Occurrence Handle11565518 Occurrence Handle10.1056/NEJMoa011161 Occurrence Handle1:CAS:528:DC%2BD3MXntlelsLk%3D
JH Song SH Cha HJ Lee SW Lee GH Park MJ Kim (2006) ArticleTitleEffect of low-dose dual blockade of the renin–angiotensin system on urinary TGF-beta in type 2 diabetic patients with advanced kidney disease Nephrol Dial Transplant 21 683–9 Occurrence Handle16330466 Occurrence Handle10.1093/ndt/gfi310 Occurrence Handle1:CAS:528:DC%2BD28XhvVeksbw%3D
T Yamamoto NA Noble AH Cohen CC Nast A Hishida LI Gold et al. (1996) ArticleTitleExpression of transforming growth factor-beta isoforms in human glomerular diseases Kidney Int 49 461–9 Occurrence Handle8821830 Occurrence Handle1:STN:280:BymH3MbgsVE%3D
S Kagami WA Border DE Miller NA Noble (1994) ArticleTitleAngiotensin II stimulates extracellular matrix protein synthesis through induction of transforming growth factor-beta expression in rat glomerular mesangial cells J Clin Invest 93 2431–7 Occurrence Handle8200978 Occurrence Handle1:CAS:528:DyaK2cXlsV2ktLw%3D
T Yamamoto T Nakamura NA Noble E Ruoslahti WA Border (1993) ArticleTitleExpression of transforming growth factor beta is elevated in human and experimental diabetic nephropathy Proc Natl Acad Sci USA 90 1814–8 Occurrence Handle7680480 Occurrence Handle10.1073/pnas.90.5.1814 Occurrence Handle1:CAS:528:DyaK3sXhs1KmsLs%3D
WA Border T Yamamoto NA Noble (1996) ArticleTitleTransforming growth factor beta in diabetic nephropathy Diabetes Metab Rev 12 309–39 Occurrence Handle9013074 Occurrence Handle10.1002/(SICI)1099-0895(199612)12:4<309::AID-DMR171>3.0.CO;2-A Occurrence Handle1:CAS:528:DyaK2sXhtFGlt7g%3D
W Wang V Koka HY Lan (2005) ArticleTitleTransforming growth factor-beta and Smad signalling in kidney diseases Nephrology (Carlton) 10 48–56 Occurrence Handle10.1111/j.1440-1797.2005.00334.x
E Gagliardini A Benigni (2006) ArticleTitleRole of anti-TGF-beta antibodies in the treatment of renal injury Cytokine Growth Factor Rev 17 89–96 Occurrence Handle16257566 Occurrence Handle10.1016/j.cytogfr.2005.09.005 Occurrence Handle1:CAS:528:DC%2BD28Xos1CrtQ%3D%3D
M Stopa D Anhuf L Terstegen P Gatsios AM Gressner S Dooley (2000) ArticleTitleParticipation of Smad2, Smad3, and Smad4 in transforming growth factor beta (TGF-beta)-induced activation of Smad7. THE TGF-beta response element of the promoter requires functional Smad binding element and E-box sequences for transcriptional regulation J Biol Chem 275 29308–17 Occurrence Handle10887185 Occurrence Handle10.1074/jbc.M003282200 Occurrence Handle1:CAS:528:DC%2BD3cXmvFGqu7c%3D
K Okamoto N Kashihara H Sugiyama T Sekikawa Y Maeshima K Kanao et al. (1997) ArticleTitleSuppression of phenotypic alteration of mesangial cells in diabetes induced in angiotensin II type 1a receptor deficient mice J Am Soc Nephrol 8 644A
T Sugaya S Nishimatsu K Tanimoto E Takimoto T Yamagishi K Imamura et al. (1995) ArticleTitleAngiotensin II type 1a receptor-deficient mice with hypotension and hyperreninemia J Biol Chem 270 18719–22 Occurrence Handle7642517 Occurrence Handle10.1074/jbc.270.32.18719 Occurrence Handle1:CAS:528:DyaK2MXnsVOjt74%3D
AA Like AA Rossini (1976) ArticleTitleStreptozotocin-induced pancreatic insulitis: new model of diabetes mellitus Science 193 415–7 Occurrence Handle180605 Occurrence Handle10.1126/science.180605 Occurrence Handle1:CAS:528:DyaE28XkvFWlsrs%3D
Y Maeshima N Kashihara T Yasuda H Sugiyama T Sekikawa K Okamoto et al. (1998) ArticleTitleInhibition of mesangial cell proliferation by E2F decoy oligodeoxynucleotide in vitro and in vivo J Clin Invest 101 2589–97 Occurrence Handle9616230
M Satoh N Kashihara Y Yamasaki K Maruyama K Okamoto Y Maeshima et al. (2001) ArticleTitleRenal interstitial fibrosis is reduced in angiotensin II type 1a receptor-deficient mice J Am Soc Nephrol 12 317–25 Occurrence Handle11158221 Occurrence Handle1:CAS:528:DC%2BD3MXhtl2msLo%3D
S Okada K Shikata M Matsuda D Ogawa H Usui Y Kido et al. (2003) ArticleTitleIntercellular adhesion molecule-1-deficient mice are resistant against renal injury after induction of diabetes Diabetes 52 2586–93 Occurrence Handle14514644 Occurrence Handle10.2337/diabetes.52.10.2586 Occurrence Handle1:CAS:528:DC%2BD3sXotVWhsb0%3D
T Yamamoto T Watanabe N Ikegaya Y Fujigaki K Matsui H Masaoka et al. (1998) ArticleTitleExpression of types I, II, and III TGF-beta receptors in human glomerulonephritis J Am Soc Nephrol 9 2253–61 Occurrence Handle9848779 Occurrence Handle1:CAS:528:DyaK1cXotVKnsr0%3D
C Hill A Flyvbjerg H Gronbaek J Petrik DJ Hill CR Thomas et al. (2000) ArticleTitleThe renal expression of transforming growth factor-beta isoforms and their receptors in acute and chronic experimental diabetes in rats Endocrinology 141 1196–208 Occurrence Handle10698197 Occurrence Handle10.1210/en.141.3.1196 Occurrence Handle1:CAS:528:DC%2BD3cXisFOrt70%3D
FN Ziyadeh DC Han (1997) ArticleTitleInvolvement of transforming growth factor-beta and its receptors in the pathogenesis of diabetic nephrology Kidney Int Suppl 60 S7–11 Occurrence Handle9285895 Occurrence Handle1:CAS:528:DyaK2sXmt1Cqt7c%3D
SW Hong M Isono S Chen MC Iglesias-De La Cruz DC Han FN Ziyadeh (2001) ArticleTitleIncreased glomerular and tubular expression of transforming growth factor-beta1, its type II receptor, and activation of the Smad signaling pathway in the db/db mouse Am J Pathol 158 1653–63 Occurrence Handle11337363 Occurrence Handle1:STN:280:DC%2BD3MzlsF2jtA%3D%3D
A Erman S Veksler U Gafter G Boner C Wittenberg DJ van Dijk (2004) ArticleTitleRenin–angiotensin system blockade prevents the increase in plasma transformIng growth factor beta 1, and reduces proteinuria and kidney hypertrophy in the streptozotocin diabetic rat J Renin Angiotensin Aldosterone Syst 5 146–51 Occurrence Handle15526251 Occurrence Handle1:CAS:528:DC%2BD2cXhtVSjt7%2FP
J Liao M Kobayashi Y Kanamuru S Nakamura Y Makita K Funabiki et al. (2003) ArticleTitleEffects of candesartan, an angiotensin II type 1 receptor blocker, on diabetic nephropathy in KK/Ta mice J Nephrol 16 841–9 Occurrence Handle14736011 Occurrence Handle1:CAS:528:DC%2BD2cXhvFajtbY%3D
JY Guh ML Yang YL Yang CC Chang LY Chuang (1996) ArticleTitleCaptopril reverses high-glucose-induced growth effects on LLC-PK1 cells partly by decreasing transforming growth factor-beta receptor protein expressions J Am Soc Nephrol 7 1207–15 Occurrence Handle8866414 Occurrence Handle1:CAS:528:DyaK28XlslKiu74%3D
L Mishra B Marshall (2006) ArticleTitleAdaptor proteins and ubiquinators in TGF-beta signaling Cytokine Growth Factor Rev 17 75–87 Occurrence Handle16359909 Occurrence Handle10.1016/j.cytogfr.2005.09.001 Occurrence Handle1:CAS:528:DC%2BD28Xos1CrtA%3D%3D
M Isono S Chen SW Hong MC Iglesias-de la Cruz FN Ziyadeh (2002) ArticleTitleSmad pathway is activated in the diabetic mouse kidney and Smad3 mediates TGF-beta-induced fibronectin in mesangial cells Biochem Biophys Res Commun 296 1356–65 Occurrence Handle12207925 Occurrence Handle10.1016/S0006-291X(02)02084-3 Occurrence Handle1:CAS:528:DC%2BD38Xms1Wlt70%3D
HC Huang PA Preisig (2000) ArticleTitleG1 kinases and transforming growth factor-beta signaling are associated with a growth pattern switch in diabetes-induced renal growth Kidney Int 58 162–72 Occurrence Handle10886561 Occurrence Handle10.1046/j.1523-1755.2000.00151.x Occurrence Handle1:CAS:528:DC%2BD3cXltVyjtLg%3D
M Ruiz-Ortega M Ruperez V Esteban J Rodriguez-Vita E Sanchez-Lopez G Carvajal et al. (2006) ArticleTitleAngiotensin II: a key factor in the inflammatory and fibrotic response in kidney diseases Nephrol Dial Transplant 21 16–20 Occurrence Handle16280370 Occurrence Handle10.1093/ndt/gfi265 Occurrence Handle1:CAS:528:DC%2BD28XisFKhtQ%3D%3D
J Rodriguez-Vita E Sanchez-Lopez V Esteban M Ruperez J Egido M Ruiz-Ortega (2005) ArticleTitleAngiotensin II activates the Smad pathway in vascular smooth muscle cells by a transforming growth factor-beta-independent mechanism Circulation 111 2509–17 Occurrence Handle15883213 Occurrence Handle10.1161/01.CIR.0000165133.84978.E2 Occurrence Handle1:CAS:528:DC%2BD2MXjvFOisro%3D
JH Li XR Huang HJ Zhu M Oldfield M Cooper LD Truong et al. (2004) ArticleTitleAdvanced glycation end products activate Smad signaling via TGF-beta-dependent and independent mechanisms: implications for diabetic renal and vascular disease Faseb J 18 176–8 Occurrence Handle12709399 Occurrence Handle10.1096/fj.04-2273com Occurrence Handle1:CAS:528:DC%2BD2cXhtVKru7bJ
J Yue KM Mulder (2000) ArticleTitleRequirement of Ras/MAPK pathway activation by transforming growth factor beta for transforming growth factor beta 1 production in a Smad-dependent pathway J Biol Chem 275 30765–73 Occurrence Handle10843986 Occurrence Handle10.1074/jbc.M000039200 Occurrence Handle1:CAS:528:DC%2BD3cXntlCjtLY%3D
W Wang XR Huang E Canlas K Oka LD Truong C Deng et al. (2006) ArticleTitleEssential role of Smad3 in angiotensin II-induced vascular fibrosis Circ Res 98 1032–9 Occurrence Handle16556868 Occurrence Handle10.1161/01.RES.0000218782.52610.dc Occurrence Handle1:CAS:528:DC%2BD28Xjs1Kltrk%3D
T Matsusaka Y Miyazaki I Ichikawa (2002) ArticleTitleThe renin angiotensin system and kidney development Annu Rev Physiol 64 551–61 Occurrence Handle11826279 Occurrence Handle10.1146/annurev.physiol.64.081501.155721 Occurrence Handle1:CAS:528:DC%2BD38XisFGmsb0%3D
W Wang XR Huang AG Li F Liu JH Li LD Truong et al. (2005) ArticleTitleSignaling mechanism of TGF-beta1 in prevention of renal inflammation: role of Smad7 J Am Soc Nephrol 16 1371–83 Occurrence Handle15788474 Occurrence Handle10.1681/ASN.2004121070 Occurrence Handle1:CAS:528:DC%2BD2MXksF2gsLk%3D
K Uchida H Suzuki T Ohashi K Nitta W Yumura H Nihei (2001) ArticleTitleInvolvement of MAP kinase cascades in Smad7 transcriptional regulation Biochem Biophys Res Commun 289 376–81 Occurrence Handle11716483 Occurrence Handle10.1006/bbrc.2001.5984 Occurrence Handle1:CAS:528:DC%2BD3MXosFGitL0%3D
A Nakao M Fujii R Matsumura K Kumano Y Saito K Miyazono et al. (1999) ArticleTitleTransient gene transfer and expression of Smad7 prevents bleomycin-induced lung fibrosis in mice J Clin Invest 104 5–11 Occurrence Handle10393693 Occurrence Handle1:CAS:528:DyaK1MXktlOgsL8%3D Occurrence Handle10.1172/JCI6094
Author information
Authors and Affiliations
Corresponding author
About this article
Cite this article
Okazaki, Y., Yamasaki, Y., Uchida, H. et al. Enhanced TGF-b/Smad signaling in the early stage of diabetic nephropathy is independent of the AT1a receptor. Clin Exp Nephrol 11, 77–87 (2007). https://doi.org/10.1007/s10157-006-0456-1
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10157-006-0456-1